George Lundberg, MD Editor in Chief at Cancer Commons

  •   George Lundberg, MD

    In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

    .

    .

  •   George Lundberg, MD

    March 2022 is Colorectal Cancer Awareness Month in the U.S., as recognized by The White House.

    .

  •   George Lundberg, MD

    Diagnosis is the basis for all treatments. As outlined in the scientific journal Neuro-Oncology, the World Health Organization (WHO) issued a new classification of central nervous system malignancies in 2021, outlining new standards for diagnosis.

    .

  •   George Lundberg, MD

    This exhaustive scientific review was published by Cureus in 2021, but remains relevant now. It explores current molecular understanding of hepatocellular carcinoma—the most common type of cancer that starts in the liver—as well as a very large range of diagnostic and treatment options. 

    .

  •   George Lundberg, MD

    As reported in the medical research journal The Lancet, adding the drug pembrolizimab (Keytruda) to chemotherapy increased progression-free survival—both clinically and statistically—for clinical trial participants with advanced breast cancer.

    .

  •   George Lundberg, MD

    As reported by Healio, immunotherapy followed by targeted therapy improved overall survival in a clinical trial with metastatic melanoma patients.

    .

  •   George Lundberg, MD

    Clinical trials can be of great importance for patients with cancer. Here is some sound background information from Cancer Commons partner Let’s Win! Pancreatic Cancer.

    .

  •   George Lundberg, MD

    Coping with a potentially lethal cancer presents many serious challenges. This article from Cancer Commons partner Let’s Win! Pancreatic Cancer might help.

    .

  •   George Lundberg, MD

    This clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.

    .

  •   George Lundberg, MD

    As announced by Cancer Commons partner the Musella Foundation For Brain Tumor Research & Information, Inc., a collaboration of groups has announced funding to support research into possible treatments for pediatric diffuse intrinsic pontine glioma (DIPG).

    .